1. Indonesia Stocks

  2. •

    Healthcare

  3. •

    Medical - Care Facilities
PT Siloam International Hospitals Tbk

PT Siloam International Hospitals Tbk

SILO.JK
PT Siloam International Hospitals TbkID flagIndonesia Stock Exchange
2,150.00
IDR
-10.00
- -
27.92TMarket Cap
PT Siloam International Hospitals Tbk
SILO.JK
(Indonesia Stock Exchange)

Recent

price

2,150.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
267.5
153.97
218.62
292.34
353.3
439.97
545.34
484.06
458.6
539.59
547.21
725.37
966.73
861.68
940.32
989.3
947.05
Revenue per Share
17.52
5.35
6.17
5.82
7.6
7.47
9.06
8.54
1.24
-26.05
8.94
52.12
70.74
93.27
69.49
85.68
80.46
Basic EPS, GAAP
-43.45
-34.41
-63.93
-69.84
-40.6
-37.37
-42.64
-261.07
-62.99
-39.51
-28.01
-48.29
-120.18
-109.95
-126.12
-138.08
-120.07
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
0.64
- -
- -
- -
- -
- -
17.36
25.38
19.66
20
- -
- -
Dividend per Share
42.06
25.16
31.33
37.57
41.35
50.97
60.92
64.73
55.06
28.52
34.05
68.29
138.3
177.9
226.58
312.4
263.03
Book Value per Share
33.38
8.35
22.43
169.42
144.03
152.98
294.99
533.42
447.51
423.86
424.27
464.24
663.77
582.22
631.6
720.18
665.6
Tangible Book Value per Share
3,852
8,179
8,179
8,564
9,456
9,419
9,477
10,961
13,006
13,006
12,993
12,934
9,846
12,987
12,982
12,986
12,983
Basic Weighted Avg Shares
1,030,472
1,259,349
1,788,083
2,503,600
3,340,793
4,144,118
5,168,363
5,305,996
5,964,650
7,017,919
7,110,124
9,381,891
9,518,012
11,190,511
12,207,563
12,847,434
12,295,929
Sales/Revenue/Turnover
9.77
7.03
5.12
3.14
5.4
5.1
5.64
5.6
4.17
3.53
6.16
12.1
11.7
15.95
14.99
13.63
13.27
Operating Margin (%)
5,579
22,078
31,921
52,481
80,774
101,659
104,655
137,452
240,331
273,106
484,424
748,296
798,506
810,317
861,813
1,028,327
949,948
Depreciation Expense
67,477
43,740
50,461
49,870
71,843
70,396
85,901
93,566
16,182
-338,772
116,163
674,117
696,495
1,211,283
902,152
1,112,663
1,044,695
Net Income, GAAP
23.19
34.4
32.54
30.06
34.84
41.65
42.71
48.25
84.12
- -
59.68
28.03
27.83
25.17
30.16
24.65
24.94
Effective Tax Rate (%)
6.55
3.47
2.82
1.99
2.15
1.7
1.66
1.76
0.27
-4.83
1.63
7.19
7.32
10.82
7.39
8.66
8.5
Profit Margin (%)
-5,457
150,883
189,104
611,544
358,453
326,305
1,180,814
1,298,595
786,514
474,840
740,217
1,306,108
508,866
498,202
-768,250
-909,117
-1,243,098
Working Capital
247,427
509,538
853,540
430,035
446,339
377,788
115,125
147,116
124,327
104,469
501,855
303,246
221,864
151,974
95,684
54,921
3,700
LT Debt
137,579
178,963
244,641
1,638,992
1,659,831
1,739,952
3,129,070
6,313,514
6,316,675
5,987,681
6,018,371
6,523,942
7,051,519
8,047,636
8,751,628
9,928,969
9,249,149
Total Equity
- -
10.11
6.7
3.42
5.55
5.78
6.19
3.14
0.6
- -
2.74
11.86
10.91
16.43
12.69
11.51
12.26
Return on Invested Capital (%)
- -
10.64
5.88
5.63
11.98
11.91
11.44
11.51
0.99
- -
15.15
51.31
40.59
48
20.03
19.61
23.56
Return on Capital (%)
- -
23.78
21.84
17.26
20.16
16.16
16.25
14.54
2.27
-62.33
28.57
101.7
62.05
65.97
34.36
31.8
36.15
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Dec'24
Mar'25
Jun'25
ST Debt
2,622,326
1,941,800
1,818,369
LT Borrowings
- -
- -
- -
LT Finance Leases
95,684
16,702
3,700
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
12,989
12,989
12,989
Market Capitalization
42,062,473
32,458,467
30,510,959

Working Capital

FRC

•

in mil. unless spec.
Dec'24
Mar'25
Jun'25
Total Current Assets
4,327,528
2,918,516
2,778,494
Cash, Cash Equivalents & STI
2,118,113
920,715
653,850
Accounts Receivable, Net
1,783,511
1,555,190
1,697,620
Inventories
202,331
199,730
159,600
Total Current Liabilities
5,095,778
4,066,408
4,021,592
Payables & Accruals
- -
- -
- -
ST Debt
2,622,326
1,941,800
1,818,369
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
22.98%
10.56%
13.45%
Free Cash Flow
69.11%
41.18%
9.52%
Net Income, GAAP
-182.42%
111.07%
23.33%
Sales/Revenue/Turnover
12.41%
13.06%
5.24%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
3,027,020
2,989,562
3,106,591
3,084,390
12,207,563
2025
3,036,971
3,067,977
3,421,901
- -
12,847,434
2026
3,277,776
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1.05
- -
- -
- -
69.49
2025
18.95
- -
- -
- -
85.68
2026
21.56
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
20
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Aatmaj Healthcare Ltd. (AATMAJ.NS)
PT Kedoya Adyaraya Tbk (RSGK.JK)
Intermedical Care and Lab Hospital Public Company Limited (IMH.BK)
Hanger, Inc. (HNGR)
Wattanapat Hospital Trang Public Company Limited (WPH.BK)
Kindly MD, Inc. (KDLYW)
Business
PT Siloam International Hospitals Tbk (SILO.JK) operates Indonesia's largest private hospital network, providing comprehensive healthcare services including specialized medical treatments, diagnostic imaging, laboratory testing, radiation therapy, emergency care, surgical procedures across multiple disciplines such as cardiology, oncology, neurology, orthopedics, obstetrics, pulmonology, and urology; general, pre-marital, heart, kidney, cancer, and visa medical check-ups; teleconsultation, home healthcare, genomic testing, and vaccination services; as well as advanced interventions like transplantation, gamma knife surgery, and brainstem surgery. The company manages over 41 hospitals and 25 clinics equipped with state-of-the-art facilities and staffed by specialists and sub-specialists, serving patients across diverse socio-economic backgrounds with a focus on accessibility and quality care. Founded in 1996 and headquartered in Tangerang, Banten, Indonesia, in the Pelita Harapan University Medical Faculty Building, Siloam extends its operations nationwide across Java, Sumatra, Bali, Kalimantan, Sulawesi, Nusa Tenggara Timur, Nusa Tenggara Barat, and Bangka Belitung, targeting individual patients, corporate clients, and government programs in the healthcare facilities and services sector. In recent developments, CVC Capital Partners acquired a controlling stake exceeding US$1 billion from PT Lippo Karawaci Tbk in 2024, establishing a joint venture structure while Lippo retains a minority interest, followed by Sight Investment Company Pte. Limited increasing its ownership to 63% through the purchase of 1.04 billion shares in December 2024. In January 2025, Marubeni Corporation signed a Memorandum of Strategic Partnership to deepen collaboration, including joint ventures in outsourcing services like laboratory testing and specialized hospitals, building on Marubeni's 2020 equity investment. The company continues expansion with new facilities such as Siloam Clinic Soe in East Nusa Tenggara in late 2023 and fertility clinic services at Siloam Hospitals Lippo Village, alongside ongoing programs like SELANGKAH breast cancer screening and uro-nephrology symposia to enhance medical expertise. Siloam, a subsidiary of Sight Investment Company Pte. Limited, maintains strategic ties with Lippo Group entities and reported nine-month earnings through September 30, 2025, underscoring its growth amid Indonesia's rising healthcare demands.